Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
British Journal Of Cancer
Edwards, S M SM; Evans, D G R DG; Hope, Q Q; Norman, A R AR; Barbachano, Y Y; Bullock, S S; Kote-Jarai, Z Z; Meitz, J J; Falconer, A A; Osin, P P; Fisher, C C; Guy, M M; Jhavar, S G SG; Hall, A L AL; O'Brien, L T LT; Gehr-Swain, B N BN; Wilkinson, R A RA; Forrest, M S MS; Dearnaley, D P DP; Ardern-Jones, A T AT; Page, E C EC; Easton, D F DF; Eeles, R A RA; ,